Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06892561 · ClinicalTrials.gov registry record
Phase-Aligned Atrial Fibrillation Mapping
A clinical trial of Atrial Fibrillation (AF), sponsored by Larisa Tereshchenko, MD, PhD.
- Active
- Registry status
- 336
- Enrollment target
- 1
- Study location
NCT06892561 is a study of Atrial Fibrillation (AF) that is active but no longer recruiting, run by Larisa Tereshchenko, MD, PhD. The registered enrollment target is 336 participants, below the 700-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06892561, a study of Atrial Fibrillation (AF), is active but no longer recruiting, sponsored by Larisa Tereshchenko, MD, PhD.
- ACTIVE NOT RECRUITING
- Registry status
- 336 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiac arrhythmia in the upper chamber of the heart (atrial fibrillation) can be cured by burning. Physicians burn very small pieces of abnormal tissue. It is important to know where to burn. The investigators propose a new way to find out where to burn. The investigators will use a new way to analyze electrical signals inside the heart and build a new electric map. The study may lead to the development of new technology. In the future, novel technology may increase the success rate and the number of cured atrial fibrillation patients. This study is a retrospective study of data collected during routine clinical care: atrial fibrillation ablations. The investigators will compare intracardiac electrograms and atrial activation maps in patients who had successful ablation outcomes (no recurrence within 1 year) and those who experienced a recurrence of arrhythmia within 1 year after the procedure.
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2023-08-16 |
| Est. Completion | 2026-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06892561
The ClinicalTrials.gov registry entry for NCT06892561 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 336 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 700-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (52% lower). The listed sponsor is Larisa Tereshchenko, MD, PhD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation (AF) appearing as the primary indexed condition, and to 0 interventions.
NCT06892561 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06892561 about?
NCT06892561 is a clinical study titled "Phase-Aligned Atrial Fibrillation Mapping". Cardiac arrhythmia in the upper chamber of the heart (atrial fibrillation) can be cured by burning. Physicians burn very small pieces of abnormal tissue. It is important to know where to burn. The investigators propose a new way to find out where to burn. The investigators will use a new way to anal...
What is the current status of trial NCT06892561?
This trial is currently active not recruiting. The enrollment target is 336 participants. The study started on 2023-08-16. Estimated completion is 2026-08-16.
What conditions does trial NCT06892561 study?
This clinical trial studies the following conditions: Atrial Fibrillation (AF).
Who is sponsoring clinical trial NCT06892561?
This trial is sponsored by Larisa Tereshchenko, MD, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06892561 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation (AF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity
RECRUITING · NA
-
Incidence of Long-TeRm Atrial Fibrillation After Acute Illness
RECRUITING
-
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
RECRUITING · NA
-
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
RECRUITING
-
Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.
RECRUITING
-
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.